Circulating Tumor Cells (CTCs) Prognostic Technologies Market Report

Global and Region Circulating Tumor Cells (CTCs) Prognostic Technologies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：221
  • REPORT CODE：GMM906256
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Circulating Tumor Cells (CTCs) Prognostic Technologies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Tumor Cells (CTCs) Prognostic Technologiesmarket, defines the market attractiveness level of Circulating Tumor Cells (CTCs) Prognostic Technologies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Circulating Tumor Cells (CTCs) Prognostic Technologies industry, describes the types of Circulating Tumor Cells (CTCs) Prognostic Technologies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Tumor Cells (CTCs) Prognostic Technologies market and the development prospects and opportunities of Circulating Tumor Cells (CTCs) Prognostic Technologies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Tumor Cells (CTCs) Prognostic Technologies market in Chapter 13.

    By Player:

    • Silicon Biosystems

    • Epic Sciences

    • Vitatex

    • Celula

    • ACDBio

    • AdnaGen

    • Rarecells

    • Fluxion Biosciences

    By Type:

    • Tumor Cell Enrichment

    • Tumor Cell Detection

    By End-User:

    • Prostate Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Lung Cancer

    • Ovarian Cancer

    • Pancreatic Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Circulating Tumor Cells (CTCs) Prognostic Technologies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Circulating Tumor Cells (CTCs) Prognostic Technologies Market Analysis and Outlook to 2022

    • 7.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.2 United States Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.4 China Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.5 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.6 India Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    • 7.7 South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption (2017-2022)

    8 Region and Country-wise Circulating Tumor Cells (CTCs) Prognostic Technologies Market Analysis and Outlook to 2028

    • 8.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.2 United States Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.4 China Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.5 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.6 India Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    • 8.7 South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast (2022-2028)

    9 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Outlook by Types and Applications to 2022

    • 9.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tumor Cell Enrichment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tumor Cell Detection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)

    10 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Outlook by Types and Applications to 2028

    • 10.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Tumor Cell Enrichment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tumor Cell Detection Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Competitive Analysis

    • 14.1 Silicon Biosystems

      • 14.1.1 Silicon Biosystems Company Details

      • 14.1.2 Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.2 Epic Sciences

      • 14.2.1 Epic Sciences Company Details

      • 14.2.2 Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.3 Vitatex

      • 14.3.1 Vitatex Company Details

      • 14.3.2 Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.4 Celula

      • 14.4.1 Celula Company Details

      • 14.4.2 Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.5 ACDBio

      • 14.5.1 ACDBio Company Details

      • 14.5.2 ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.6 AdnaGen

      • 14.6.1 AdnaGen Company Details

      • 14.6.2 AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.7 Rarecells

      • 14.7.1 Rarecells Company Details

      • 14.7.2 Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • 14.8 Fluxion Biosciences

      • 14.8.1 Fluxion Biosciences Company Details

      • 14.8.2 Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Circulating Tumor Cells (CTCs) Prognostic Technologies

    • Figure Circulating Tumor Cells (CTCs) Prognostic Technologies Picture

    • Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption by Country (2017-2022)

    • Figure United States Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Figure China Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Figure Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Figure India Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast by Country (2022-2028)

    • Figure United States Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Cell Enrichment Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Cell Detection Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Cell Enrichment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Cell Detection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Export by Region (Top 5 Countries) (2017-2028)

    • Table Silicon Biosystems (Foundation Year, Company Profile and etc.)

    • Table Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table Epic Sciences (Foundation Year, Company Profile and etc.)

    • Table Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table Vitatex (Foundation Year, Company Profile and etc.)

    • Table Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table Celula (Foundation Year, Company Profile and etc.)

    • Table Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table ACDBio (Foundation Year, Company Profile and etc.)

    • Table ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table AdnaGen (Foundation Year, Company Profile and etc.)

    • Table AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table Rarecells (Foundation Year, Company Profile and etc.)

    • Table Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service

    • Table Fluxion Biosciences (Foundation Year, Company Profile and etc.)

    • Table Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US